Advertisement

Current Pain and Headache Reports

, Volume 14, Issue 4, pp 276–283 | Cite as

Migraine and Epilepsy: A Focus on Overlapping Clinical, Pathophysiological, Molecular, and Therapeutic Aspects

  • Marino Muxfeldt BianchinEmail author
  • Renata Gomes Londero
  • José Eduardo Lima
  • Marcelo Eduardo Bigal
Article

Abstract

The association of epilepsy and migraine has been long recognized. Migraine and epilepsy are both chronic disorders with episodic attacks. Furthermore, headache may be a premonitory or postdromic symptom of seizures, and migraine headaches may cause seizures per se (migralepsy). Migraine and epilepsy are comorbid, sharing pathophysiological mechanisms and common clinical features. Several recent studies identified common genetic and molecular substrates for migraine and epilepsy, including phenotypic-genotypic correlations with mutations in the CACNA1A, ATP1A2, and SCN1A genes, as well as in syndromes due to mutations in the SLC1A3, POLG, and C10orF2 genes. Herein, we review the relationship between migraine and epilepsy, focusing on clinical aspects and some recent pathophysiological and molecular studies.

Keywords

Comorbidity Headache Migraine Epilepsy Paroxysmal disorders 

Notes

Acknowledgments

Dr. Marino M. Bianchin is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico grant #305501/2007-0.

Disclosure

Dr. Marcelo E. Bigal is a full-time employee of Merck & Co., and holds stocks and stock options in the company. No other potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• Stovner LJ, Hagen K, Jensen R, et al.: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193–210. This article is a comprehensive review about the global impact of headache disorders according to headache type. CrossRefPubMedGoogle Scholar
  2. 2.
    Lipton RB, Bigal ME: Migraine: epidemiology, impact, and risk factors for progression. Headache 2005, 45(Suppl 1):S3–S13.CrossRefPubMedGoogle Scholar
  3. 3.
    Sander JW, Shorvon SD: Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996, 61:433–443. (Published erratum appears in J Neurol Neurosurg Psychiatry 1997, 62:679.)CrossRefPubMedGoogle Scholar
  4. 4.
    de Boer HM, Mula M, Sander JW: The global burden and stigma of epilepsy. Epilepsy Behav 2008, 12:540–546.CrossRefPubMedGoogle Scholar
  5. 5.
    Pace BP, Sullivan-Fowler M: JAMA 100 years ago: A slander on the medical profession. JAMA 1996, 276:1222b.CrossRefPubMedGoogle Scholar
  6. 6.
    •• Haut SR, Bigal ME, Lipton RB: Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006, 5:148–157. This excellent review examines similarities and contrasts between migraine and epilepsy. CrossRefPubMedGoogle Scholar
  7. 7.
    Andermann F, Andermann E: Migraine and epilepsy, with special reference to the benign epilepsies of childhood. Epilepsy Res Suppl 1992, 6:207–214.PubMedGoogle Scholar
  8. 8.
    Ottman R, Lipton RB: Comorbidity of migraine and epilepsy. Neurology 1994, 44:2105–2110.PubMedGoogle Scholar
  9. 9.
    Ottman R, Lipton RB: Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology 1996, 47:918–924.PubMedGoogle Scholar
  10. 10.
    Di Clemente L, Coppola G, Magis D, et al.: Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? Brain 2007, 130:765–770.CrossRefPubMedGoogle Scholar
  11. 11.
    Leniger T, von den Driesch S, Isbruch K, et al.: Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 2003, 43:672–677.CrossRefPubMedGoogle Scholar
  12. 12.
    Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24 (Suppl 1):9–160.Google Scholar
  13. 13.
    Bernasconi A, Andermann F, Bernasconi N, et al.: Lateralizing value of peri-ictal headache: A study of 100 patients with partial epilepsy. Neurology 2001, 56:130–132.PubMedGoogle Scholar
  14. 14.
    Yankovsky AE, Andermann F, Bernasconi A: Characteristics of headache associated with intractable partial epilepsy. Epilepsia 2005, 46:1241–1245.CrossRefPubMedGoogle Scholar
  15. 15.
    Cai S, Hamiwka LD, Wirrell EC: Peri-ictal headache in children: prevalence and character. Pediatr Neurol 2008, 39:91–96.CrossRefPubMedGoogle Scholar
  16. 16.
    Yankovsky AE, Andermann F, Mercho S, et al.: Preictal headache in partial epilepsy. Neurology 2005, 65:1979–1981.CrossRefPubMedGoogle Scholar
  17. 17.
    Laplante P, Saint-Hilaire JM, Bouvier G: Headache as an epileptic manifestation. Neurology 1983, 33:1493–1495.PubMedGoogle Scholar
  18. 18.
    Moskowitz MA: Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment. Funct Neurol 2007, 22:133–136.PubMedGoogle Scholar
  19. 19.
    Marks DA, Ehrenberg BL: Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 1993, 43:2476–2483.PubMedGoogle Scholar
  20. 20.
    Leniger T, Isbruch K, von den Driesch S, et al.: Seizure-associated headache in epilepsy. Epilepsia 2001, 42:1176–1179.CrossRefPubMedGoogle Scholar
  21. 21.
    Piccioli M, Parisi P, Tisei P, et al.: Ictal headache and visual sensitivity. Cephalalgia 2009, 29:194–203.CrossRefPubMedGoogle Scholar
  22. 22.
    Isler H, Wirsen ML, Elli N: Hemicrania epileptica: synchronous ipsilateral ictal headache with migraine features. In Migraine and Epilepsy. Edited by Andermann F, Lugaresi E. Boston: Butterworths; 1987:246–263.Google Scholar
  23. 23.
    Guerrini R, Genton P: Epileptic syndromes and visually induced seizures. Epilepsia 2004, 45(Suppl 1):14–18.CrossRefPubMedGoogle Scholar
  24. 24.
    Ito M, Adachi N, Nakamura F, et al.: Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia 2004, 24:23–28.CrossRefPubMedGoogle Scholar
  25. 25.
    Ogunyemi A, Adams D: Migraine-like symptoms triggered by occipital lobe seizures: response to sumatriptan. Can J Neurol Sci 1998, 25:151–153.PubMedGoogle Scholar
  26. 26.
    Caraballo RH, Cersósimo RO, Fejerman N: Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia 2008, 49:288–297.CrossRefPubMedGoogle Scholar
  27. 27.
    • Taylor I, Berkovic SF, Kivity S, Scheffer IE: Benign occipital epilepsies of childhood: clinical features and genetics. Brain 2008, 131:2287–2294. The authors examine early and late benign occipital epilepsies of childhood as two discrete electroclinical syndromes, exploring clinical features and clinical genetics of these two syndromes.CrossRefPubMedGoogle Scholar
  28. 28.
    Panayiotopoulos CP, Michael M, Sanders S, et al.: Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain 2008, 131:2264–2286.CrossRefPubMedGoogle Scholar
  29. 29.
    Caraballo R, Koutroumanidis M, Panayiotopoulos CP, Fejerman N: Idiopathic childhood occipital epilepsy of Gastaut: a review and differentiation from migraine and other epilepsies. J Child Neurol 2009, 24:1536–1542.CrossRefPubMedGoogle Scholar
  30. 30.
    Wirrell EC, Hamiwka LD: Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia 2006, 47:1674–1681.CrossRefPubMedGoogle Scholar
  31. 31.
    Clarke T, Baskurt Z, Strug LJ, Pal DK: Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 2009, 50:2428–2433.CrossRefPubMedGoogle Scholar
  32. 32.
    Deprez L, Peeters K, Van Paesschen W, et al.: Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology 2007, 68:1995–2002.CrossRefPubMedGoogle Scholar
  33. 33.
    Deprez L, Weckhuysen S, Peeters K, et al.: Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia 2008, 49:500–508.CrossRefPubMedGoogle Scholar
  34. 34.
    • Barrett CF, van den Maagdenberg AM, Frants RR, Ferrari MD: Familial hemiplegic migraine. Adv Genet 2008, 63:57–83. The authors review clinical features of migraine and discuss the continuing highway of migraine gene discovery.CrossRefPubMedGoogle Scholar
  35. 35.
    Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646–657.CrossRefPubMedGoogle Scholar
  36. 36.
    Engel J Jr; International League Against Epilepsy (ILAE): A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796–803.CrossRefPubMedGoogle Scholar
  37. 37.
    • Crompton DE, Berkovic SF: The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol 2009, 8:370–381. The authors present an interesting discussion about clinical and molecular similarities and differences of epileptic seizures from other paroxysmal disorders.CrossRefPubMedGoogle Scholar
  38. 38.
    Wild E: Deja vu in neurology. J Neurol 2005, 252:1–7.Google Scholar
  39. 39.
    Gaitatzis A, Sander JW: The mortality of epilepsy revisited. Epileptic Disord 2004, 6:3–13.PubMedGoogle Scholar
  40. 40.
    Goadsby PJ, Hoskin KL: Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain 1996, 67:355–359.CrossRefPubMedGoogle Scholar
  41. 41.
    Hargreaves R: New migraine and pain research. Headache 2007, 47(Suppl 1):S26–S43.CrossRefPubMedGoogle Scholar
  42. 42.
    •• de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM: Molecular genetics of migraine. Hum Genet 2009, 126:115–132. This is an excellent and comprehensive review about molecular aspects of migraine.CrossRefPubMedGoogle Scholar
  43. 43.
    Bahra A, Matharu MS, Buchel C, et al.: Brainstem activation specific to migraine headache. Lancet 2001, 357:1016–1017.CrossRefPubMedGoogle Scholar
  44. 44.
    Goadsby PJ: Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 2002, 22:107–111.CrossRefPubMedGoogle Scholar
  45. 45.
    Lauritzen M: Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994, 117:199–210.Google Scholar
  46. 46.
    Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136–142.CrossRefPubMedGoogle Scholar
  47. 47.
    Ayata C, Jin H, Kudo C, et al.: Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006, 59:652–661.CrossRefPubMedGoogle Scholar
  48. 48.
    Aurora SK: Is chronic migraine one end of a spectrum of migraine or a separate entity? Cephalalgia 2009, 29:597–605.CrossRefPubMedGoogle Scholar
  49. 49.
    Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543–552.CrossRefPubMedGoogle Scholar
  50. 50.
    Tottene A, Conti R, Fabbro A, et al.: Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 2009, 61:762–773.CrossRefPubMedGoogle Scholar
  51. 51.
    Gargus JJ: Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Ann N Y Acad Sci 2009, 1151:133–156.CrossRefPubMedGoogle Scholar
  52. 52.
    De Fusco M, Marconi R, Silvestri L, et al.: Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003, 33:192–196.CrossRefPubMedGoogle Scholar
  53. 53.
    Castro MJ, Stam AH, Lemos C, et al.: Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine. J Hum Genet 2007, 52:990–998.CrossRefPubMedGoogle Scholar
  54. 54.
    Dichgans M, Freilinger T, Eckstein G, et al.: Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371–377.CrossRefPubMedGoogle Scholar
  55. 55.
    Gambardella A, Marini C: Clinical spectrum of SCN1A mutations. Epilepsia 2009, 50(Suppl 5):20–23.CrossRefPubMedGoogle Scholar
  56. 56.
    Fujiwara T: Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res 2006, 70(Suppl 1):S223–S230.CrossRefPubMedGoogle Scholar
  57. 57.
    • Harkin LA, McMahon JM, Iona X, et al.: The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007, 130:843–852. The authors present an expanded spectrum of epileptic encephalopathies associated with SCN1A mutations.CrossRefPubMedGoogle Scholar
  58. 58.
    Claes LR, Deprez L, Suls A, et al.: The SCN1A variant database: a novel research and diagnostic tool. Hum Mutat 2009, 30:E904–E920.CrossRefPubMedGoogle Scholar
  59. 59.
    Jen JC, Wan J, Palos TP, et al.: Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005, 65:529–534.CrossRefPubMedGoogle Scholar
  60. 60.
    Tzoulis C, Engelsen BA, Telstad W, et al.: The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006, 129:1685–1692.CrossRefPubMedGoogle Scholar
  61. 61.
    Lönnqvist T, Paetau A, Valanne L, Pihko H: Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009, 132:1553–1562.CrossRefPubMedGoogle Scholar
  62. 62.
    Silberstein SD: Clinical practice guidelines. Cephalalgia 2005, 25:765–766.CrossRefPubMedGoogle Scholar
  63. 63.
    Silberstein SD: Topiramate in migraine prevention: evidence-based medicine from clinical trials. Neurol Sci 2004, 25(Suppl 3):S244–S245.CrossRefPubMedGoogle Scholar
  64. 64.
    Rapoport AM, Bigal ME: Migraine preventive therapy: current and emerging treatment options. Neurol Sci 2005, 26(Suppl 2):s111–s120.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marino Muxfeldt Bianchin
    • 1
    Email author
  • Renata Gomes Londero
    • 2
  • José Eduardo Lima
    • 3
  • Marcelo Eduardo Bigal
    • 4
    • 5
  1. 1.Division of Neurology, Hospital de Clínicas de Porto AlegreUniversidade Federal do Rio Grande do SulRio Grande do SulBrazil
  2. 2.Medical Science Postgraduate ProgramUniversidade Federal do Rio Grande do SulPorto AlegreBrazil
  3. 3.Department of Medicine, School of MedicineUniversidade Federal de São CarlosSão CarlosBrazil
  4. 4.Global Director of Scientific Affairs: Neurology and Psychiatry, Merck Research LaboratoriesUpper GwyneddUSA
  5. 5.Department of NeurologyAlbert Einstein College of MedicineNew YorkUSA

Personalised recommendations